熱門資訊> 正文

Maravai LifeSciences通过1.8亿美元的信贷安排对债务进行再融资;降低未偿借款

2026-06-03 21:45

Maravai Lifesciences Holdings, Inc. Class A(MRVI) 0

Maravai LifeSciences (MRVI) announced on Wednesday that its subsidiaries signed a new credit agreement including a $150M term loan facility and a $30M revolving credit facility.
The company used the new loan and about $98.5M in cash to repay debt under its previous credit agreement due in October 2027.
The refinancing cuts the company's long-term debt to $150M from about $242.9M and extends the maturity to June 2032, while keeping additional liquidity available for future growth.
Source: Press Release

More on Maravai LifeSciences Holdings

Maravai LifeSciences: Better Earnings Drive Gains That Ought To Be Sustainable
Maravai LifeSciences Holdings, Inc. (MRVI) Q1 2026 Earnings Call Transcript
Maravai LifeSciences Holdings, Inc. 2026 Q1 - Results - Earnings Call Presentation
Maravai LifeSciences Holdings GAAP EPS of -$0.02 beats by $0.07, revenue of $65.8M beats by $12.8M
Maravai LifeSciences Holdings Q1 2026 Earnings Preview

推薦文章

風險及免責提示：以上內容僅代表作者的個人立場和觀點，不代表華盛的任何立場，華盛亦無法證實上述內容的真實性、準確性和原創性。投資者在做出任何投資決定前，應結合自身情況，考慮投資產品的風險。必要時，請諮詢專業投資顧問的意見。華盛不提供任何投資建議，對此亦不做任何承諾和保證。